Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine exosome injection for frozen embryo transfer in women with thin endometrium
IRCT20150105020558N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of endothelial progenitor cell-derived exosomes in uterine factor infertility (UFI) and Endometrial hypotrophy (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Biochemical pregnancy. Started Oct 2024; status: completed.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
uterine factor infertility (UFI)Endometrial hypotrophy
Beyond the preview
Go deeper on IRCT20150105020558N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150105020558N8.